MedTrace Logo

Psychotherapy for Anxiety in Children With Autism Spectrum Disorder

NCT02028247 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 214

Last updated 2021-11-15

Study results available
· View outcomes & findings →

Summary

Anxiety disorders affect 40 to 50% of children with autism spectrum disorders (ASD), contributing to substantial distress and impairment. The goal of this study is to examine the effectiveness of a personalized type of psychotherapy against standard-care psychotherapy for addressing anxiety in youth with ASD.

Conditions

  • Autism Spectrum Disorders
  • Autism
  • Asperger's Syndrome
  • Pervasive Developmental Disability - Not Otherwise Specified
  • Obsessive-compulsive Disorder
  • Social Phobia
  • Generalized Anxiety Disorder
  • Specific Phobia
  • Separation Anxiety Disorder

Interventions

BEHAVIORAL

Personalized Cognitive-behavioral therapy

BEHAVIORAL

Standard Practice Cognitive-behavioral therapy

BEHAVIORAL

Treatment as Usual

Sponsors & Collaborators

Principal Investigators

  • Eric A Storch, Ph.D. · University of South Florida

  • Jeff Wood, Ph.D. · University of California, Los Angeles

  • Philip C Kendall, Ph.D. · Temple University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2018-01-31
Completion
2018-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02028247 on ClinicalTrials.gov